Browse

Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment

Cited 45 time in Web of Science Cited 47 time in Scopus
Authors
Moon, H-G; Han, W; Lee, J W; Ko, E; Kim, E-K; Yu, J-H; Kang, S Y; Moon, W K; Cho, N; Park, I-A; Oh, D-Y; Han, S-W; Im, S-A; Noh, D-Y
Issue Date
2009-01-31
Publisher
Oxford University Press
Citation
Ann Oncol. 2009; 20(4): 636-641
Keywords
AdultAge FactorsAntineoplastic Agents/administration & dosage/*therapeutic useBreast Neoplasms/drug therapy/*pathologyChemotherapy, AdjuvantCohort Studies*Genes, erbB-2HumansMagnetic Resonance Imaging/*standardsMiddle AgedMultivariate Analysis
Abstract
BACKGROUND: Although recent studies suggest high accuracy of breast magnetic resonance imaging (MRI) in predicting residual tumor extent after neo-adjuvant systemic treatment (NST), its use is still controversial. In this study, we aimed to identify predictive factors of MRI accuracy after NST to determine a subgroup of patients in whom the use of MRI provides best additional benefit. MATERIALS AND METHODS: Clinicopathologic and molecular profiles of breast cancer patients were investigated and their relationships with MRI accuracy were analyzed. RESULTS: From January 2006 to February 2008, 195 patients received NST and preoperative MRI. In overall, MRI predicted residual tumor extent with higher accuracy than ultrasonography. Triple-negative (TN) tumors showed highest correlation between MRI-measured and pathologic tumor size (r = 0.781) when compared with other subtypes. Multivariate analysis showed age and HER2 expression status as independent factors predicting MRI accuracy. When patients were classified based on their age and HER2 status, relatively older patients (>45) with HER2-negative tumors showed highest MRI accuracy. This finding was further validated using an independent cohort of 63 consecutive patients. CONCLUSION: Age and HER2 status independently affected MRI accuracy after NST. This observation may guide more tailored approach in using MRI in breast cancer patients undergoing NST.
ISSN
1569-8041 (Electronic)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19179551

http://annonc.oxfordjournals.org/cgi/reprint/20/4/636.pdf

http://hdl.handle.net/10371/67859
DOI
https://doi.org/10.1093/annonc/mdn683
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse